Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review
Abstract
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ostrom, Q.T.; Gittleman, H.; Xu, J.; Kromer, C.; Wolinsky, Y.; Kruchko, C.; Barnholtz-Sloan, J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013. Neuro Oncol. 2016, 18, v1–v75. [Google Scholar] [CrossRef] [PubMed]
- Ostrom, Q.T.; Gittleman, H.; Truitt, G.; Boscia, A.; Kruchko, C.; Barnholtz-Sloan, J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol. 2018, 20, iv1–iv86. [Google Scholar] [CrossRef]
- Lin, D.D.; Lin, J.L.; Deng, X.Y.; Li, W.; Li, D.D.; Yin, B.; Lin, J.; Zhang, N.; Sheng, H.S. Trends in intracranial meningioma incidence in the United States, 2004–2015. Cancer Med. 2019, 8, 6458–6467. [Google Scholar] [CrossRef] [PubMed]
- Ostrom, Q.T.; Gittleman, H.; de Blank, P.M.; Finlay, J.L.; Gurney, J.G.; McKean-Cowdin, R.; Stearns, D.S.; Wolff, J.E.; Liu, M.; Wolinsky, Y.; et al. American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012. Neuro Oncol. 2016, 18 (Suppl. S1), i1–i50. [Google Scholar] [CrossRef] [PubMed]
- Perry, A.; Giannini, C.; Raghavan, R.; Scheithauer, B.W.; Banerjee, R.; Margraf, L.; Bowers, D.C.; Lytle, R.A.; Newsham, I.F.; Gutmann, D.H. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: A clinicopathologic study of 53 cases. J. Neuropathol. Exp. Neurol. 2001, 60, 994–1003. [Google Scholar] [CrossRef] [PubMed]
- Sievers, P.; Chiang, J.; Schrimpf, D.; Stichel, D.; Paramasivam, N.; Sill, M.; Gayden, T.; Casalini, B.; Reuss, D.E.; Dalton, J.; et al. YAP1-fusions in pediatric NF2-wildtype meningioma. Acta Neuropathol. 2020, 139, 215–218. [Google Scholar] [CrossRef] [PubMed]
- Goutagny, S.; Bah, A.B.; Henin, D.; Parfait, B.; Grayeli, A.B.; Sterkers, O.; Kalamarides, M. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: Clinical, radiological, and molecular features. Neuro Oncol. 2012, 14, 1090–1096. [Google Scholar] [CrossRef]
- Bachir, S.; Shah, S.; Shapiro, S.; Koehler, A.; Mahammedi, A.; Samy, R.N.; Zuccarello, M.; Schorry, E.; Sengupta, S. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int. J. Mol. Sci. 2021, 22, 690. [Google Scholar] [CrossRef]
- Plotkin, S.R.; Messiaen, L.; Legius, E.; Pancza, P.; Avery, R.A.; Blakeley, J.O.; Babovic-Vuksanovic, D.; Ferner, R.; Fisher, M.J.; Friedman, J.M.; et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet. Med. 2022, 24, 1967–1977. [Google Scholar] [CrossRef]
- Zhang, N.; Bai, H.; David, K.K.; Dong, J.; Zheng, Y.; Cai, J.; Giovannini, M.; Liu, P.; Anders, R.A.; Pan, D. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 2010, 19, 27–38. [Google Scholar] [CrossRef]
- Zheng, X.; Guo, S.; Liu, D.; Chu, J.; Li, Y.; Wang, X.; Zhang, X.; Song, C.; Huang, Q. Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: A case report and literature review. BMC Pediatr. 2022, 22, 694. [Google Scholar] [CrossRef] [PubMed]
- Esposito, S.; Marucci, G.; Antonelli, M.; Miele, E.; Modena, P.; Giagnacovo, M.; Massimino, M.; Biassoni, V.; Taddei, M.; Schiariti, M.P.; et al. Interhemispheric Pediatric Meningioma, YAP1 Fusion-Positive. Diagnostics 2022, 12, 2367. [Google Scholar] [CrossRef] [PubMed]
- Szulzewsky, F.; Arora, S.; Arakaki, A.K.S.; Sievers, P.; Almiron Bonnin, D.A.; Paddison, P.J.; Sahm, F.; Cimino, P.J.; Gujral, T.S.; Holland, E.C. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. Genes Dev. 2022, 36, 857–870. [Google Scholar] [CrossRef] [PubMed]
- Yagi, R.; Chen, L.F.; Shigesada, K.; Murakami, Y.; Ito, Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999, 18, 2551–2562. [Google Scholar] [CrossRef]
- Szulzewsky, F.; Holland, E.C.; Vasioukhin, V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev. Biol. 2021, 475, 205–221. [Google Scholar] [CrossRef]
- Huang, J.; Wu, S.; Barrera, J.; Matthews, K.; Pan, D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122, 421–434. [Google Scholar] [CrossRef]
- Cooper, J.; Giancotti, F.G. Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett. 2014, 588, 2743–2752. [Google Scholar] [CrossRef]
- Schieffer, K.M.; Agarwal, V.; LaHaye, S.; Miller, K.E.; Koboldt, D.C.; Lichtenberg, T.; Leraas, K.; Brennan, P.; Kelly, B.J.; Crist, E.; et al. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Am. J. Surg. Pathol. 2021, 45, 329–340. [Google Scholar] [CrossRef]
- Jadik, S.; Stan, A.C.; Dietrich, U.; Pietila, T.A.; Elsharkawy, A.E. Intraparenchymal meningioma mimicking cavernous malformation: A case report and review of the literature. J. Med. Case Rep. 2014, 8, 467. [Google Scholar] [CrossRef]
- Laraba, L.; Hillson, L.; de Guibert, J.G.; Hewitt, A.; Jaques, M.R.; Tang, T.T.; Post, L.; Ercolano, E.; Rai, G.; Yang, S.M.; et al. Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. Brain 2023, 146, 1697–1713. [Google Scholar] [CrossRef]
- Szulzewsky, F.; Arora, S.; Hoellerbauer, P.; King, C.; Nathan, E.; Chan, M.; Cimino, P.J.; Ozawa, T.; Kawauchi, D.; Pajtler, K.W.; et al. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis. Genes Dev. 2020, 34, 1051–1064. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nobee, A.; Xu, M.; Seth, A.; Rong, Y. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review. Int. J. Mol. Sci. 2023, 24, 12814. https://doi.org/10.3390/ijms241612814
Nobee A, Xu M, Seth A, Rong Y. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review. International Journal of Molecular Sciences. 2023; 24(16):12814. https://doi.org/10.3390/ijms241612814
Chicago/Turabian StyleNobee, Alisa, Mei Xu, Anjali Seth, and Yuan Rong. 2023. "Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review" International Journal of Molecular Sciences 24, no. 16: 12814. https://doi.org/10.3390/ijms241612814
APA StyleNobee, A., Xu, M., Seth, A., & Rong, Y. (2023). Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review. International Journal of Molecular Sciences, 24(16), 12814. https://doi.org/10.3390/ijms241612814